Injectable codeine is available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may result in nonimmune mast-cell degranulation and resulting anaphylactoid response. Codeine suppositories may also be promoted in a few nations around the world. In Eire, new regulations came into impact on 1 August 2010[90] https://codeingil.com/